NEW YORK (360Dx) – Avista Capital Partners today announced a definitive agreement to buy anatomic pathology laboratory Miraca Life Sciences.

A new holding company called Symphony Buyer has been formed to become the new owner of MLS, which currently is a wholly owned subsidiary of Japanese holding firm Miraca Holdings. The basic enterprise value of the deal is approximately $175.6 million, Miraca Holdings said, adding it will own 15 percent of Symphony Buyer's shares.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.